Evaluation of protective potency of coconut oil-based probiotic against antibiotic-induced compromised gastrointestinal attributes and associated complications in Swiss albino mice
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20243024Keywords:
Coconut oil, Probiotics, Dysbiosis, Inflammation, Oxidative stress, Neurobehavioral, Gut-organ axisAbstract
Background: Antibiotic-induced gastrointestinal toxicity is a major concern globally. The gut-organ axis has been explicitly studied, and hence, any damage to the gut ecosystem directly or indirectly manifests into compromised multi-organ functions. Therefore, the present study was designed to explore the protective potency of coconut oil-probiotic (C-PRO) against antibiotic-induced compromised gastrointestinal attributes and associated complications.
Methods: Animals were divided into 5 groups (n=6). Normal saline was given to the control group; the antibiotic cocktail was given to the antibiotic group. In the treatment group, low and high doses of C-PRO were given post-antibiotic treatment. In the per se group, only a high dose of C-PRO was given. After 28 days, animals were studied for neurobehavioral parameters and scarified. Blood and organs were collected and stored for histopathological, immune histochemical, and biochemical analysis.
Results: Antibiotic treatment reduced body weight, increased oxidative stress, and caused histopathological damage to the stomach, duodenum, colon, brain, heart, liver, lungs, kidney, spleen, and testis. It also altered biochemical parameters such as lactate dehydrogenase (LDH), creatine kinase-myocardial band (CK-MB), alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transferase (GGT), albumin, creatinine, urea, uric acid, and blood urea nitrogen (BUN). Additionally, Antibiotic exposure in mice exhibited depressive-like behaviour and declined cognitive function. The treatment with a low dose of C-PROs showed negligible protective effect, whereas a high dose of C-PRO effectively reversed the structural, biochemical, and neurobehavioral attributes toward normal.
Conclusions: We conclude that the synergistic effect of coconut oil and probiotics, which have potent antioxidant and anti-inflammatory effects, might be responsible for multidimensional protective effects against compromised gastrointestinal attributes and associated complications.
Metrics
References
Lathakumari RH, Vajravelu LK, Satheesan A, Ravi S, Thulukanam J. Antibiotics and the Gut Microbiome: Understanding the Impact on Human Health. Med Microecol. 2024;20:100106.
Li J, Pu F, Peng C, Wang Y, Zhang Y, Wu S, et al. Antibiotic cocktail-induced gut microbiota depletion in different stages could cause host cognitive impairment and emotional disorders in adulthood in different manners. Neurobiol Dis. 2022;170:105757.
Ji X, Su L, Zhang P, Yue Q, Zhao C, Sun X, et al. Lentinan improves intestinal inflammation and gut dysbiosis in antibiotics-induced mice. Sci Rep. 2022;12(1):19609.
Saxami G, Kerezoudi EN, Eliopoulos C, Arapoglou D, Kyriacou A. The Gut-Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics. Life (Basel). 2023;13(10):2023.
Wang P, Tu K, Cao P, Yang Y, Zhang H, Qiu XT, et al. Antibiotics-induced intestinal dysbacteriosis caused behavioral alternations and neuronal activation in different brain regions in mice. Mol Brain. 2021;14(1):49.
Ding W, You Z, Chen Q, Yang L, Doheny J, Zhou X, et al. Gut Microbiota Influences Neuropathic Pain Through Modulating Proinflammatory and Anti-inflammatory T Cells. Anesth Analg. 2021;132(4):1146-55.
Zhang MM, Liu SB, Chen T, Koga K, Zhang T, Li YQ, et al. Effects of NB001 and Gabapentin on Irritable Bowel Syndrome-Induced Behavioral Anxiety and Spontaneous Pain. Mol Brain. 2014;7:1-15.
Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders. Gastroenterology. 2016;S0016-5085(16)00222-5.
Roy Sarkar S, Mitra Mazumder P, Banerjee S. Probiotics protect against gut dysbiosis associated decline in learning and memory. J Neuroimmunol. 2020;348:577390.
Aslan I, Tarhan Celebi L, Kayhan H, Kizilay E, Gulbahar MY, Kurt H, et al. Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats. Pharmaceuticals (Basel). 2023;16(7):1041.
Djurasevic S, Bojic S, Nikolic B, Dimkic I, Todorovic Z, Djordjevic J, et al. Beneficial Effect of Virgin Coconut Oil on Alloxan-Induced Diabetes and Microbiota Composition in Rats. Plant Foods Hum Nutr. 2018;73(4):295-301.
Saxena R, Mittal P, Clavaud C, Dhakan DB, Roy N, Breton L, et al. Longitudinal Study of the Scalp Microbiome Suggests Coconut Oil to Enrich Healthy Scalp Commensals. Sci Rep. 2021;11:1-14.
Matsue M, Mori Y, Nagase S, Sugiyama Y, Hirano R, Ogai K, et al. Measuring the Antimicrobial Activity of Lauric Acid against Various Bacteria in Human Gut Microbiota Using a New Method. Cell Transplant. 2019;28(12):1528-41.
Marklund S, Marklund G. Involvement of the Superoxide Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay for Superoxide Dismutase. Eur J Biochem. 1974;47:469-74.
Claiborne A, Fridovich I. Purification of the o-dianisidine peroxidase from Escherichia coli B. Physicochemical characterization and analysis of its dual catalatic and peroxidatic activities. J Biol Chem. 1979;254(10):4245-52.
Sedlak J, Lindsay RH. Estimation of Total, Protein-Bound, and Nonprotein Sulfhydryl Groups in Tissue with Ellman’s Reagent. Anal Biochem. 1968;25:192-205.
Ohkawa H, Ohishi N, Yagi K. Assay for Lipid Peroxides in Animal Tissues by Thiobarbituric Acid Reaction. Anal Biochem. 1979;95:351-8.
Kraeuter AK, Guest PC, Sarnyai Z. The Forced Swim Test for Depression-Like Behavior in Rodents. Method Mol Biol. 2019;1916:75-80.
Saadullah M, Fakhar-e-Alam M, Muzammil S, Asif M, Siddique MH, Rashad M, et al. Evaluation of Molecular Mechanisms Responsible for in Vivo Anti-Alzheimer’s Property of Euphorbia Cotinifolia Methanol Extract. J King Saud Univ Sci. 2023;35:102785.
Shi Y, Kellingray L, Zhai Q, Gall GL, Narbad A, Zhao J, et al. Structural and Functional Alterations in the Microbial Community and Immunological Consequences in a Mouse Model of Antibiotic-Induced Dysbiosis. Front Microbiol. 2018;9:1948.
Nakamura YK, Metea C, Karstens L, Asquith M, Gruner H, Moscibrocki C, et al. Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis. Invest Ophthalmol Vis Sci. 2016;57(8):3747-58.
Guillouzo A, Guguen-Guillouzo C. Antibiotics-Induced Oxidative Stress. Curr Opin Toxicol. 2020;20-1.
Narayana K. An Aminoglycoside Antibiotic Gentamycin Induces Oxidative Stress, Reduces Antioxidant Reserve and Impairs Spermatogenesis in Rats. J Toxicol Sci. 2008;33:85-96.
Adams HR, Parker JL, Durrett LR. Cardiac Toxicities of Antibiotics. Environ Health Perspect. 1978;26:217-23.
Campbell RE, Chen CH, Edelstein CL. Overview of Antibiotic-Induced Nephrotoxicity. Kidney Int Rep. 2023;8:2211.
Azambuja E, Fleck JF, Batista RG, Menna Barreto SS. Bleomycin Lung Toxicity: Who Are the Patients with Increased Risk? Pulm Pharmacol Ther. 2005;18:363-6.
Robles M, Toscano E, Cotta J, Lucena MI, Andrade RJ. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment. Curr Drug Saf. 2010;5(3):212-22.
Matsiras D, Bezati S, Ventoulis I, Verras C, Parissis J, Polyzogopoulou E. Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut-Heart Axis. J Clin Med. 2023;12(7):2567.
Ding JH, Jin Z, Yang XX, Lou J, Shan WX, Hu YX, et al. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol. 2020;26(40):6141-62.
Arab JP, Martin-Mateos RM, Shah VH. Gut–Liver Axis, Cirrhosis and Portal Hypertension: The Chicken and the Egg. Hepatol Int. 2018;12:24-33.
Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014;111(42):E4485-93.
Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, et al. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis. Hepatology. 2020;71(2):522-38.
Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504-16.
Schnabl B, Brenner DA. Interactions between the Intestinal Microbiome and Liver Diseases. Gastroenterology. 2014;146:1513-24.
Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 2013;58(1):120-7.
Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60(5):940-7.
Bamgbola O. Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab. 2016;7(3):136-47.
Fröhlich EE, Farzi A, Mayerhofer R, Reichmann F, Jačan A, Wagner B, et al. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain Behav Immun. 2016;56:140-55.
Desbonnet L, Clarke G, Traplin A, O'Sullivan O, Crispie F, Moloney RD, et al. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun. 2015;48:165-73.
Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264-76.
Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-52.
Urani A, Philbert J, Cohen C, Griebel G. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice. Pharmacol Biochem Behav. 2011;98(3):425-31.
El Hage W, Peronny S, Griebel G, Belzung C. Impaired memory following predatory stress in mice is improved by fluoxetine. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(1):123-8.
McEwen BS. Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain. Physiol Rev. 2007;87:873-904.
Dwivedi Y, Rizavi HS, Pandey GN. Antidepressants Reverse Corticosterone-Mediated Decrease in Brain-Derived Neurotrophic Factor Expression: Differential Regulation of Specific Exons by Antidepressants and Corticosterone. Neuroscience. 2006;139:1017-29.
Naert G, Zussy C, Tran Van Ba C, Chevallier N, Tang YP, Maurice T, et al. Involvement of Endogenous Brain-Derived Neurotrophic Factor in Hypothalamic-Pituitary-Adrenal Axis Activity. J Neuroendocrinol. 2015;27(11):850-60.
Singh H, Chopra C, Singh H, Malgotra V, Khurshid Wani A, Singh Dhanjal D, et al. Gut-Brain Axis and Alzheimer’s Disease: Therapeutic Interventions and Strategies. J Funct Foods. 2024;112:105915.
 
			
		 
			 
			